These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36314271)

  • 1. Naloxone Versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.
    Habeeb EA; Tran LK; Goodberlet MZ; Lupi KE; DeGrado JR; Dube KM
    Ann Pharmacother; 2023 Jul; 57(7):762-768. PubMed ID: 36314271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit.
    Merchan C; Altshuler D; Papadopoulos J
    Ann Pharmacother; 2017 Mar; 51(3):203-208. PubMed ID: 28168885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
    Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD006332. PubMed ID: 36106667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylnaltrexone for the treatment of opioid-induced constipation.
    Bader S; Dürk T; Becker G
    Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):13-26. PubMed ID: 23265145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylnaltrexone for the Treatment of Constipation in Critically Ill Children.
    López J; Fernández SN; Santiago MJ; Urbano J; González R; Fernández-Llamazares C; López-Herce J
    J Clin Gastroenterol; 2016 Apr; 50(4):351-2. PubMed ID: 26950234
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylnaltrexone: treatment for opioid-induced constipation.
    Licup N; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis.
    Peacock WF; Slatkin NE; Israel RJ; Stambler N
    J Emerg Med; 2022 Feb; 62(2):231-239. PubMed ID: 34893381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxegol rescue with methylnaltrexone highly effective.
    Brocklebank J; Miller EJ; Fingas S
    BMJ Support Palliat Care; 2020 Sep; 10(3):316-317. PubMed ID: 32709705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.
    Gatti A; Sabato AF
    Clin Drug Investig; 2012 May; 32(5):293-301. PubMed ID: 22413747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of methylnaltrexone to induce laxation in acutely injured patients with burns and necrotizing soft-tissue infections.
    Hewitt K; Lin H; Faraklas I; Morris S; Cochran A; Saffle J
    J Burn Care Res; 2014; 35(2):e106-11. PubMed ID: 23877147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms.
    Iyer SS; Randazzo BP; Tzanis EL; Schulman SL; Zhang H; Wang W; Manley AL
    Value Health; 2011 Jan; 14(1):177-83. PubMed ID: 21211500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylnaltrexone for opioid-induced constipation in a pediatric oncology patient.
    Kissling KT; Mohassel LR; Heintz J
    J Pain Symptom Manage; 2012 Jul; 44(1):e1-3. PubMed ID: 22770490
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of abdominal pain during methylnaltrexone treatment of opioid-induced constipation in advanced illness: a post hoc analysis of two clinical trials.
    Slatkin NE; Lynn R; Su C; Wang W; Israel RJ
    J Pain Symptom Manage; 2011 Nov; 42(5):754-60. PubMed ID: 22045373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects.
    Sanders M; Jones S; Löwenstein O; Jansen JP; Miles H; Simpson K
    Pain Med; 2015 Aug; 16(8):1540-50. PubMed ID: 26110375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.
    Murphy JA; Sheridan EA
    Ann Pharmacother; 2018 Apr; 52(4):370-379. PubMed ID: 29092627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [News from the cochrane library: mu opioid antagonists for opioid-induced bowel dysfunction].
    Meerpohl JJ; Timmer A
    Z Gastroenterol; 2008 Sep; 46(9):917-21. PubMed ID: 18810678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
    Baker DE
    Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexone.
    Woo M; O'Connor M; Yuan CS; Moss J
    Anesth Analg; 2008 Dec; 107(6):1965-7. PubMed ID: 19020145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methylnaltrexone. A new approach for therapy of opioid-induced obstipation].
    Chappell D; Conzen P
    Schmerz; 2009 Oct; 23(5):471-8. PubMed ID: 19690895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-Induced Constipation Part 2: Newer Therapies #295.
    Badke A; Rosielle DA
    J Palliat Med; 2015 Oct; 18(10):893-4. PubMed ID: 26439728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.